MSC2364447C Phase 1b in Systemic Lupus Erythematosus

NCT02537028 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Lupus Erythematosus, Systemic

Interventions

DRUG: MSC2364447C
DRUG: MSC2364447C
DRUG: Placebo

Sponsor

EMD Serono Research & Development Institute, Inc.

Collaborators

[object Object]